Pharmabiz49m
CD (Suzhou) Biopharma gets US FDA clearance to begin phase I trial of CD-001
Biopharma gets US FDA clearance to begin phase I trial of CD-001: Suzhou, China Monday, September 23, 2024, 18:00 Hrs [IST] CD(Suzhou) Biopharma, a rapidly advancing c ...
Pharmabiz1h
XpertDox, Blue Fish Pediatrics partner to enhance medical coding efficiency with AI-powered healthcare coding software
XpertDox, Blue Fish Pediatrics partner to enhance medical coding efficiency with AI-powered healthcare coding software: Phoenix Monday, September 23, 2024, 17:00 Hrs [IST] XpertDo ...
Pharmabiz2h
EMA’s human medicines committee recommends approval of Henlius’ Hansizhuang to treat extensive-stage small cell lung cancer
EMA’s human medicines committee recommends approval of Henlius’ Hansizhuang to treat extensive-stage small cell lung cancer: Shanghai, China Monday, September 23, 2024, 16:00 ...
Pharmabiz5h
EMA committee recommends marketing approval for AbbVie’s mirvetuximab soravtansine for the treatment of certain adult ovarian cancer
North Chicago, Illinois Monday, September 23, 2024, 13:00 Hrs [IST] ...
Pharmabiz4h
EU CHMP recommends approval of Merck’s Keytruda regimens as treatment for patients with two types of gynaecologic cancers
EU CHMP recommends approval of Merck’s Keytruda regimens as treatment for patients with two types of gynaecologic cancers ...
Pharmabiz3h
Governments progress on negotiations for a pandemic agreement to boost global preparedness for future emergencies
Governments progress on negotiations for a pandemic agreement to boost global preparedness for future emergencies: Geneva, Switzerland Monday, September 23, 2024, 15:00 Hrs [IST] ...
Pharmabiz7h
EMA committee recommends approval of Sanofi & Regeneron’s Dupixent to treat eosinophilic esophagitis in children as young as 1 year old
EMA committee recommends approval of Sanofi & Regeneron’s Dupixent to treat eosinophilic esophagitis in children as young as 1 year old: Paris Monday, September 23, 2024, 11:00 ...
Pharmabiz6h
Samsung Bioepis, Biogen receive positive CHMP opinion for aflibercept biosimilar, Opuviz
Samsung Bioepis, Biogen receive positive CHMP opinion for aflibercept biosimilar, Opuviz: Incheon, Korea Monday, September 23, 2024, 12:00 Hrs [IST] Samsung Bioepis Co., Ltd., a b ...
Pharmabiz9h
US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration
US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration: Cambridge, UK Monday, September 23, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science- ...
Pharmabiz8h
EMA’s human medicines committee recommends marketing approval for Pfizer & BioNTech’s Omicron KP.2-adapted Covid-19 vaccine
EMA’s human medicines committee recommends marketing approval for Pfizer & BioNTech’s Omicron KP.2-adapted Covid-19 vaccine: New York Monday, September 23, 2024, 10:00 Hrs [IS ...
Pharmabiz5h
FIPO Kerala chapter to celebrate WPD on September 25 in Thiruvananthapuram
World Pharmacist Day, the largest global platform for pharmacy public outreach, will be celebrated in Kerala this year under the leadership of the state unit of the Federation of Indian Pharmacists ...
Pharmabiz10h
Indian pharma working to transition from ‘Inspection Readiness’ to ‘Perpetual Regulatory Readiness’
Indian pharma is working to transition from ‘Inspection Readiness’ to ‘Perpetual Regulatory Readiness’. This is at a time when several US FDA observations on regulatory compliance to highlight areas ...